Table 2.

Age-adjusted ORs and 95% CIs for AMH quartiles and prostate cancer risk

Cases
AMH quartiles (ng/mL)ControlsTotalAggressiveaNonaggressiveb
Q1 (0.04–2.64)2482221.00 (reference)781.00 (reference)1341.00 (reference)
Q2 (2.65–4.21)2492601.17 (0.91–1.50)1071.39 (0.99–1.95)1501.11 (0.83–1.48)
Q3 (4.22–6.74)2522601.16 (0.90–1.49)971.26 (0.89–1.78)1591.15 (0.86–1.54)
Q4 (6.75–25.0)2502561.15 (0.89–1.48)851.14 (0.80–1.63)1671.22 (0.91–1.63)
Ptrend0.1340.5120.074

NOTE: There were 21 prostate cancer cases that could not be classified to a subtype due to missing tumor characteristics.

  • aAggressive prostate cancer: biopsy Gleason ≥ 7, or clinical stage ≥III, or fatal.

  • bNonaggressive prostate cancer: biopsy Gleason ≤ 6, and clinical stage I or II.